Physician
Gastroenterology
Dr. John C. Hoefs, MD
|
|
Give Review
John Hoefs works in the field of Gastroenterology. He graduated from George Washington University School of Medicine. George Washington University School of Medicine is ranked 67/0 in Research/PrimaryCare. He over the years received 1 awards: "Super Doctor". John Hoefs is a published doctor and has 83 publications published. The lastest was: 'Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy.
- Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis C.
- Frequency of Elevated Hepatocellular Carcinoma (HCC) Biomarkers in Patients With Advanced Hepatitis C.
- Testing beneficial therapy in human cirrhosis using animal models of cirrhosis.
- Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
- Noninvasive evaluation of liver disease severity.
- Factors affecting the quantitative liver-spleen scan in normal individuals.
- Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shunt.
- Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.
- Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial.
- The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial.
- Raising the dose of interferon does not improve the response in chronic hepatitis C.
- The liver-spleen scan as a quantitative liver function test: correlation with liver severity at peritoneoscopy.
- Hepatitis B surface antigen in pancreatic and biliary secretions.
- The mechanism of ascitic fluid protein concentration increase during diuresis in patients with chronic liver disease.
- Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease.
- Determinants of serum bile acids in chronic liver disease.
- Functional measurement of nonfibrotic hepatic mass in cirrhotic patients.
- Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.
- Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Stu...
- A novel, simple method of functional spleen volume calculation by liver-spleen scan.
- Diagnostic paracentesis.
- Globulin correction of the albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradients.
- Measurement of portal shunting in dogs.
- Diagnostic paracentesis. A potent clinical tool.
- Spontaneous bacterial peritonitis: prevention and therapy.
- Diagnosis and hemodynamic assessment of portal hypertension.
- Ascitic fluid analysis in malignancy-related ascites.
- Hepatofugal portal flow in cirrhosis: observations on hepatic hemodynamics and the nature of the arterioportal communications.
- Glucose intolerance and hepatic, biliary tract and pancreatic dysfunction.
- Spontaneous bacterial peritonitis.
- Polymicrobial bacterascites. A unique entity in the spectrum of infected ascitic fluid.
- Spontaneous vs secondary bacterial peritonitis. Differentiation by response of ascitic fluid neutrophil count to antimicrobial therapy.
- Ascites kinetics in cirrhosis: relationship to plasma-ascites hydrostatic-oncotic balance and intensity of renal sodium retention.
- Estimation of acoustic attenuation in liver using one megabyte of data and the zero-crossings technique.
- Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals.
- Immune complexes and cryoproteins in ascitic fluid of patients with alcoholic liver disease.
- Immune complexes in the portal and systemic circulation of patients with alcoholic liver diseases.
- Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid.
- A new method for the measurement of intrahepatic shunts.
- Mechanism for the abnormal liver scan in acute alcoholic liver injury.
- Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis.
- Is the concept of "exudative" ascites useful?
- Peritoneal lymphomatosis with ascites. A characterization.
- Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis.
- Ascitic fluid chemical analysis before, during and after spontaneous bacterial peritonitis.
- Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
- Does hepatitis B virus grow outside the liver.
- Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease.
- Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
- Noninvasive measurement of nutrient portal blood shunting.
- Prevalence of hepatitis B-associated delta agent among mentally retarded carriers of HBsAg.
- Portal blood pressure after intrahepatic megaislet allotransplantation in rats.
- Effect of short-term bile duct ligation on peripheral blood steroids, urinary PGE2 and the rate of sodium excretion in male rabbits.
- Frequency-demodulated US: evaluation in the liver. Work in progress.
- In vivo acoustic attenuation in liver: correlations with blood tests and histology.
- Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
- Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.
- Biotin transport in human liver basolateral membrane vesicles: a carrier-mediated, Na+ gradient-dependent process.
- [C13/C12 Ratios in human urinary calculi].
- [Carbon isotopic composition of chicken eggshells].
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
- Effect of chronic portal hypertension on glutamine transport across rat intestinal brush border and basolateral membranes.
- 5-Methyltetrahydrofolate transport in basolateral membrane vesicles from human liver.
- Perfused Kupffer cell mass. Correlation with histology and severity of chronic liver disease.
- Intraperitoneal coagulation in chronic liver disease ascites.
- Carbon isotope composition of carbonaceous matter from the precambrian of the witwatersrand system.
- Geochemistry of Precambrian carbonates: II. Archean greenstone belts and Archean sea water.
- Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.
- Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
- Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
- Treatment of chronic HCV infection in special populations.
- Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans.
- Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
- Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
- The clinical presentation of chronic hepatitis B virus infection in Asian Americans: a single center retrospective study.
- Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
- Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
- Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
- Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
- Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.
Doctors Specialties
- Internal Medicine
- Gastroenterology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
George Washington University -
George Washington University School of Medicine
Hospital
-
Hoag Memorial Hospital Presbyterian
Drug Facts
| NPI NUMBER | 1154425742 | |
| NPPES Provider LastName | HOEFS | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 926183716 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 458.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154425742 |
| Last Name Of The Provider | HOEFS |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Anita Bajpai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie M. Chan, MD |
|
|
Dr. Miki Csintalan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Adeela R. Ahsan, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason A. Dugan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Molood Hadi, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa H. Lim, MD |
|
|
Dr. Juliana Mathewson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fang F. Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jun-Ichi Ohara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Kaufman, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Whan S. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane J. Wu, MD |